Read E.V.I.dently Today for current news about health policy and events, among other topics.
E.V.I.dently Today Blog
On November 9-10, 2016, the Food and Drug Administration will host a stakeholder meeting to obtain input on how biopharmaceutical companies and others are allowed to exchange information, such as health care economic data and other types of evidence, with health care decision-makers.
Treatment for chronic conditions account for most health costs in the United States. So as health care providers shift to innovative delivery models to provide value-based care while being held accountable for costs, chronic disease management plays a large role in how these models are developed.
How do we measure the value of a medical intervention, its benefits to patients, and the associated costs to patients, payers and society as a whole? Hundreds of stakeholders gathered in-person and online to tackle this question at the National Pharmaceutical Council’s Assessing Value: Promise & Pitfalls conference on September 29.